Skip to main content
Home
FULL MENU Close Menu
Home
Home

Jennifer Smith

Jennifer Smith is the editor of Oncology Practice, part of MDedge Hematology/Oncology. She was previously the editor of Hematology Times, an editor at Principal Investigators Association, and a reporter at The Oneida Daily Dispatch. She has a BS in journalism.

News

Next-generation sequencing test detects pathogens with high sensitivity

Author:
Jennifer Smith
Publish date: May 11, 2019

NEW ORLEANS – The test detected pathogens with 92% sensitivity, which was more sensitive than conventional testing methods.

  • Read More

News

Inhibitor may overcome ibrutinib resistance in MCL

Author:
Jennifer Smith
Publish date: May 10, 2019

The inhibitor, IACS-010759, decreased tumor growth and prolonged survival in mouse models of ibrutinib-resistant lymphoma.

  • Read More

Video

Researchers propose new risk groups for NK-AML

Author:
Jennifer Smith
Publish date: May 8, 2019

NEWPORT BEACH, CALIF. – Investigators used machine learning algorithms to risk stratify patients with normal karyotype acute myeloid leukemia.

  • Read More

News

Gabapentin falls short in treating sickle cell pain

Author:
Jennifer Smith
Publish date: May 6, 2019

NEW ORLEANS – Gabapentin plus standard therapy produced results similar to those of placebo plus standard therapy.

  • Read More

News

Researchers win Stand Up To Cancer grants

Author:
Jennifer Smith
Publish date: May 6, 2019

Five teams received funding for research into leukemia and lung, colon, pancreatic, breast, and ovarian cancers.

  • Read More

Video

Combo proves most effective in HMA-naive, higher-risk MDS

Author:
Jennifer Smith
Publish date: May 3, 2019

NEWPORT BEACH, CALIF. – Oral rigosertib plus azacitidine produced a 90% response rate in higher-risk patients with myelodysplastic syndromes who...

  • Read More

Video

More abnormal cells linked to poorer ASCT outcomes in MDS

Author:
Jennifer Smith
Publish date: May 3, 2019

NEWPORT BEACH, CALIF. – Patients with more than 60% cytogenetically abnormal cells at transplant had inferior overall survival and relapse-free...

  • Read More

News

LentiGlobin reduces transfusion dependence in young thalassemia patients

Author:
Jennifer Smith
Publish date: May 3, 2019

NEW ORLEANS – Children and young adults with non-beta0/beta0 thalassemia achieved transfusion independence in two trials.

  • Read More

Video

Biomarker testing may transform treatment of acute GVHD

Author:
Jennifer Smith
Publish date: April 26, 2019

NEWPORT BEACH, CALIF. – Testing patient blood samples for two biomarkers may help guide early treatment of acute GVHD.

  • Read More

News

Tagraxofusp produces high response rate in BPDCN

Author:
Jennifer Smith
Publish date: April 24, 2019

The overall response rate was 90% in previously untreated patients who received the highest dose.

  • Read More

Video

Model inspired by Netflix, Amazon may help guide MDS treatment

Author:
Jennifer Smith
Publish date: April 23, 2019

NEWPORT BEACH, CALIF. – The researchers used an algorithm to help predict response or resistance to lenalidomide with a high degree of accuracy....

  • Read More

News

Researchers to be honored at ASPHO

Author:
Jennifer Smith
Publish date: April 22, 2019

Hematology and oncology researchers will receive awards at the 2019 American Society of Pediatric Hematology/Oncology conference.

  • Read More

Video

Sorafenib plus GCLAM held safe in AML, MDS phase-1 study

Author:
Jennifer Smith
Publish date: April 22, 2019

NEWPORT BEACH, CALIF. – Sorafenib plus GCLAM has shown promise in a phase 1 trial of patients with AML and MDS.

  • Read More

Video

Study highlights lack of data on transgender leukemia patients

Author:
Jennifer Smith
Publish date: April 19, 2019

NEWPORT BEACH, CALIF. – Researchers identified transgender leukemia patients by detecting gender-karyotype mismatches.

  • Read More

Video

ALF 2019 showcases evolving treatment of AML

Author:
Jennifer Smith
Publish date: April 19, 2019

NEWPORT BEACH, CALIF. – Dr. Martin Tallman discusses meeting presentations on the treatment of AML.

  • Read More

Pages

  • « first
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close